Globally, vaccine researchers are working on nonantibiotic methods to prevent recurrent urinary tract infections (rUTIs) as antibiotic resistance becomes a growing threat to this painful disease.
In the United States, about 40% of women develop a UTI at some point in their lifetime, as well as many men.
According to an article by Carissa Wong published in the journal Nature on May 2, 2024, the latest prevention approaches include an oral spray vaccine.
Vaccination Reduces Recurrent Urinary Tract Infections in Women
Fewer Flu and Pneumonia Deaths Reported
In the 20th century, influenza and pneumonia constituted the most significant proportion of infectious disease deaths in the United States. However, in the 21st century, that trend changed.
On May 20, 2024, a Major Article published by the journal AJIC analyzed crude death rates (CR) and age-adjusted mortality rates (AAMR) per 100,000 individuals calculated using influenza and pneumonia mortality data (ICD-10 Codes: J09-J18) from the U.S. CDC WONDER database.
Fewer Flu and Pneumonia Deaths Reported
In the 20th century, influenza and pneumonia constituted the most significant proportion of infectious disease deaths in the United States. However, in the 21st century, that trend changed.
On May 20, 2024, a Major Article published by the journal AJIC analyzed crude death rates (CR) and age-adjusted mortality rates (AAMR) per 100,000 individuals calculated using influenza and pneumonia mortality data (ICD-10 Codes: J09-J18) from the U.S. CDC WONDER database.
Is the United States Prepared for Mpox Clade I Arrival
Compared with the clade II mpox virus (MPXV) outbreak in adults that started in May 2022, the ongoing clade I MPXV outbreak in Africa is causing severe illness and higher mortality.
The U.S. Centers for Disease Control and Prevention (CDC) reported on May 16, 2024, that the increasing number of reported suspected clade I mpox cases in the Democratic Republic of the Congo (DRC) poses a global threat for potential spread.
New Malaria Vaccine Shipments Begin
With the World Health Organization (WHO) 's recent Prequalification, a second malaria vaccine may soon become available in various countries.
The WHO estimates that the demand for malaria vaccines will be 40–60 million doses annually by 2026.
Meningococcal Cases Linked to Recent Travel
The Centers for Disease Control and Prevention (CDC) today issued a Health Alert Network (HAN) Health Advisory to notify healthcare providers about cases of meningococcal disease associated with Umrah, which is conducted in the Kingdom of Saudi Arabia (KSA).
Meningococcal disease, caused by Neisseria meningitidis, is a rare but severe illness with a 10–15% case-fatality rate.
Long COVID Definitions, Care Models Are Evolving
Care models are informed by five key principles, including multidisciplinary expertise, patient-centered approach
Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD Patients
No reduction seen in number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both
2015 to 2021 Saw Increase in Electronic Vaping Product Use in Teens
During all time periods, highest percentages of EVP use seen for adolescents in grade 12
Advanced UTI Treatments Becoming Available
While antibiotics have treated most Urinary Tract Infections (UTIs) over the past, resistance to these medications has been expanding. About 20% of infected people are reportedly resistant to UTI antibiotics.
This is an unfortunate trend, as complicated UTIs may lead to hospitalized florid urosepsis, which can be fatal.
According to recent news, innovative UTI treatments are accelerating in clinical trials and gaining regulatory approvals to meet the needs of millions of women and men impacted by this common infectious disease.